Live Quote · NASDAQNVAXHealthcare· Biotechnology

Novavax, Inc.

$7.47▼ 3.24%($-0.25)
MKT CAP $1.23BNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
69/100
▌ Solid
93
Valuation
60
Profitability
100
Growth
64
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NVAX research report →

Analyst Price Target
$8.00+7.1% vs. today

Range $8 – $8

Analyst RatingBuy
16 Buy3 Hold4 Sell

Price Chart

+20.10% · this period
$12.82$9.52$6.22Nov 20May 26Nov 20
52-Week Range17% of range
Low
$6.25
Current
$7.47
High
$13.39